In a turbulent period for biotech firms, Evaxion Biotech AS (EVAX) has seen its stock price plummet to $2.38, though InvestingPro analysis suggests the stock may be undervalued. According to ...
RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...
In this week’s edition of InnovationRx, we look at HHS nominee Robert F. Kennedy Jr.’s first Senate confirmation hearing, the ...
A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...
Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of ...
C the Signs is using AI to sharpen predictions on cancer risk.
Imvax is targeting the same form of brain cancer that claimed the lives of former Phillies pitcher Tug McGraw and catcher ...
Meet the woman leading vaccine innovation in Senegal to fight Rift Valley fever and empower Africa’s next generation of ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.